Senobi Exercises with Jacobson’s Muscular Relaxation Exercises in Chronic Obstructive Pulmonary Disease
DOI:
https://doi.org/10.61919/jhrr.v6i2.1932Keywords:
Chronic obstructive pulmonary disease; Dyspnea; Progressive muscle relaxation; Pulmonary function; Sleep quality; Senobi exercises.Abstract
Background: Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and symptom burden, particularly exertional dyspnea and sleep disturbance, which contribute to functional decline and impaired quality of life. Objective: To compare the effects of Senobi exercises versus Jacobson progressive muscle relaxation (PMR) on pulmonary function, dyspnea, functional capacity, and sleep quality in adults with COPD. Methods: An assessor-blinded randomized clinical trial was conducted at Sarwet Anver Medical Complex, Lahore, enrolling 40 adults (35–50 years) with COPD (stage 2–3). Participants were randomized to Senobi (Group A, n=20) or Jacobson PMR (Group B, n=20), delivered alongside conventional COPD care for 8 weeks. Outcomes included spirometry (FVC, FEV1), Modified Borg Dyspnea Scale following a 6-minute walk test procedure, and sleep quality via the SATED questionnaire, assessed pre- and post-intervention. Results: Both groups improved significantly within-group across all outcomes (p<0.001). Between-group post-intervention comparisons favored Jacobson PMR for dyspnea (mean difference −2.30 Borg units; p=0.0004) and functional capacity score (mean difference 1.40; p=0.0009), while Senobi favored sleep quality (mean difference −0.70 SATED units; p=0.0006). Spirometric post-intervention differences favored Jacobson PMR numerically but were not statistically robust with the reported dispersion. Conclusion: Both interventions were beneficial; Jacobson PMR showed greater benefit for dyspnea and functional capacity, whereas Senobi showed greater benefit for sleep quality.
Downloads
References
Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2019;18(114):213-221.
Rodrigues SdO, Cunha CMCd, Soares GMV, Silva PL, Silva AR, Goncalves-de-Albuquerque CF. Mechanisms, pathophysiology, and currently proposed treatments of chronic obstructive pulmonary disease. Pharmaceuticals. 2021;14(10):979.
Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18(1):67.
Balkissoon R, Lommatzsch S, Carolan B, Make B. Chronic obstructive pulmonary disease: a concise review. Med Clin North Am. 2021;95(6):1125-1141.
Varmaghani M, Dehghani M, Heidari E, Sharifi F, Moghaddam SS, Farzadfar F. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J. 2019;25(1):47-57.
Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2).
Laucho-Contreras ME, Cohen-Todd M. Early diagnosis of COPD: myth or a true perspective. Eur Respir Rev. 2020;29(158).
Alfahad AJ, Alzaydi MM, Aldossary AM, Alshehri AA, Almughem FA, Zaidan NM, Tawfik EA. Current views in chronic obstructive pulmonary disease pathogenesis and management. Saudi Pharm J. 2021;29(12):1361-1373.
Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447-458.
Simpson SJ, Turkovic L, Wilson AC, Verheggen M, Logie KM, Pillow JJ, Hall GL. Lung function trajectories throughout childhood in survivors of very preterm birth: a longitudinal cohort study. Lancet Child Adolesc Health. 2018;2(5):350-359.
Agusti A, Alcazar B, Cosio B, Echave JM, Faner R, Izquierdo JL, et al. Time for a change: anticipating the diagnosis and treatment of COPD. Eur Respir Soc; 2020.
Jia X, Zhou S, Luo D, Zhao X, Zhou Y, Cui Ym. Effect of pharmacist-led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: a systematic review and meta-analysis. J Clin Pharm Ther. 2020;45(5):904-917.
Zhang S, King D, Rosen VM, Ismaila AS. Impact of single combination inhaler versus multiple inhalers to deliver the same medications for patients with asthma or COPD: a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020:417-438.
Hurst JR, Skolnik N, Hansen GJ, Anzueto A, Donaldson GC, Dransfield MT, Varghese P. Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life. Eur J Intern Med. 2020;73:1-6.
Song J, Zeng M, Wang H, Qin C, Hou HY, Sun ZY, et al. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19. Allergy. 2021;76(2):483-496.
Bailey KL. The importance of the assessment of pulmonary function in COPD. Med Clin North Am. 2019;96(4):745-752.
Kakavas S, Kotsiou OS, Perlikos F, Mermiri M, Mavrovounis G, Gourgoulianis K, Pantazopoulos I. Pulmonary function testing in COPD: looking beyond the curtain of FEV1. NPJ Prim Care Respir Med. 2021;31(1):23.
O’Donnell DE, Milne KM, James MD, de Torres JP, Neder JA. Dyspnea in COPD: new mechanistic insights and management implications. Adv Ther. 2020;37:41-60.
Bülbüloğlu S, Kaplan Serin E. Effect of perceived dyspnea on attitude toward death from the perspective of COPD patients. OMEGA. 2023;86(3):913-929.
Ries AL. Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. Am J Med. 2018;119(10):12-20.
Bhullar S, Phillips B. Sleep in COPD patients. COPD. 2020;2(3):355-361.
McNicholas WT, Verbraecken J, Marin JM. Sleep disorders in COPD: the forgotten dimension. Eur Respir Rev. 2018;22(129):365-375.
Clímaco DCS, Lustosa TC, Silva MVdFP, Lins-Filho OL, Rodrigues VK, de Oliveira Neto LdAP, et al. Sleep quality in COPD patients: correlation with disease severity and health status. J Bras Pneumol. 2022;48:e20210340.
Stewart NH, Walters RW, Mokhlesi B, Lauderdale DS, Arora VM. Sleep in hospitalized patients with chronic obstructive pulmonary disease: an observational study. J Clin Sleep Med. 2020;16(10):1693-1699.
Egan C, Deering BM, Blake C, Fullen BM, McCormack NM, Spruit MA, Costello RW. Short term and long term effects of pulmonary rehabilitation on physical activity in COPD. Respir Med. 2020;106(12):1671-1679.
Sahin H, Varol Y, Naz I, Aksel N, Tuksavul F, Ozsoz A. The effect of pulmonary rehabilitation on COPD exacerbation frequency per year. Clin Respir J. 2018;12(1):165-174.
Kahnert K, Alter P, Young D, Lucke T, Heinrich J, Huber RM, et al. The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir Med. 2018;134:79-85.
Herawati I, Hapsari DO. The effect of Jacobson’s relaxation therapy on shortness of breath in patients with chronic bronchitis. Proceeding ISETH (International Summit on Science, Technology, and Humanity). 2017:57-63.
Neşe A, Bağlama SS. The effect of progressive muscle relaxation and deep breathing exercises on dyspnea and fatigue symptoms of COPD patients: a randomized controlled study. Holist Nurs Pract. 2022;36(4):E18-E26.
Yona S, Dahlia D. Effect of progressive muscle relaxation on sleep quality among patients with chronic diseases: a literature review. Belitung Nurs J. 2020;6(2):30-34.
Yohannes AM, Junkes-Cunha M, Smith J, Vestbo J. Management of dyspnea and anxiety in chronic obstructive pulmonary disease: a critical review. J Am Med Dir Assoc. 2017;18(12):1096.e1-1096.e17.
Yilmaz CK, Kapucu S. The effect of progressive relaxation exercises on fatigue and sleep quality in individuals with COPD. Holist Nurs Pract. 2017;31(6):369-377.
Sato K, Kawamura T, Abo T. “Senobi” stretch ameliorates asthma symptoms by restoring autonomic nervous system balance. J Investig Med. 2020;58(8):968-970.
Sato K, Kawamura T, Yamagiwa S. The “Senobi” breathing exercise is recommended as first line treatment for obesity. Biomed Res. 2020;31(4):259-262.
Banno M, Harada Y, Taniguchi M, Tobita R, Tsujimoto H, Tsujimoto Y, et al. Exercise can improve sleep quality: a systematic review and meta-analysis. PeerJ. 2018;6:e5172.
Esteban C, Arostegui I, Aramburu A, Moraza J, Najera-Zuloaga J, Aburto M, et al. Predictive factors over time of health-related quality of life in COPD patients. Respir Res. 2020;21:1-11.
Selzler A-M, Habash R, Robson L, Lenton E, Goldstein R, Brooks D. Self-efficacy and health-related quality of life in chronic obstructive pulmonary disease: a meta-analysis. Patient Educ Couns. 2020;103(4):682-692.
Priego-Jiménez S, Cavero-Redondo I, Pascual-Morena C, Martínez-García I, Martínez-Vizcaíno V, Álvarez-Bueno C. Effect of different exercise programs on lung function in people with chronic obstructive pulmonary disease: a network meta-analysis of RCTs. Ann Phys Rehabil Med. 2024;67(2):101792.
Basso FM, de Almeida Araújo T, da Silva MMC, Di Lorenzo VAP. Association between baseline dyspnea and physical activity level in COPD patients after a pulmonary rehabilitation program. Braz J Phys Ther. 2024;28:100730.
IŞIKEL H, Sebahat G, TAPAN ÖO, Dongaz Öİ. Effect of relaxation exercises on dyspnea and sleep quality in chronic obstructive pulmonary disease. J Med Palliat Care. 2022;4(1):7-12.
Kılıç Z, Karadağ S, Tutar N. The effect of progressive relaxation exercises on dyspnea and anxiety levels in individuals with COPD: a randomized controlled trial. Holist Nurs Pract. 2023;37(1):E14-E23.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Laiba Sjjad, Moeed Jamil, Anam Shahzadi, Namra Jamshad
This work is licensed under a Creative Commons Attribution 4.0 International License.
Public Licensing Terms
This work is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this license:
- You are free to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, including commercial use.
- Attribution must be given to the original author(s) and source in a manner that is reasonable and does not imply endorsement. If changes were made to the material, this must be indicated.
- No additional restrictions may be applied that conflict with the terms of this license.
For more details, visit: https://creativecommons.org/licenses/by/4.0/
